Status:
ACTIVE_NOT_RECRUITING
Biomarkers for Pharmacoresponse in Bipolar Disorder - Coagulation
Lead Sponsor:
Karolinska Institutet
Conditions:
Bipolar Disorder
Eligibility:
All Genders
18-100 years
Brief Summary
Previous studies indicate an association between severe psychiatric disorders, such as bipolar disorder, and increased risk of venous thromboembolism. However, to which extent this association is infl...
Detailed Description
The investigators will analyse differences in coagulation * using a case-control design where cases are bipolar patients not yet treated with lithium, and controls are healthy volunteers (Swedish eth...
Eligibility Criteria
Inclusion
- Patients diagnosed with bipolar disorder but not yet treated with lithium, where there is a decision by the patient and the responsible doctor to start lithium treatment.
Exclusion
- Inability to give informed consent
Key Trial Info
Start Date :
February 24 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2025
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT06581822
Start Date
February 24 2017
End Date
April 1 2025
Last Update
February 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska Institutet
Stockholm, Sweden, 17176